Theseus Pharmaceuticals IPO

theseusrx.com

Theseus Pharmaceuticals is committed to outsmarting cancer resistance by developing best-in-class, pan-variant kinase inhibitors, to shape the future of targeted oncology.

Founded2017
Register for Details

For more details on financing and valuation for Theseus Pharmaceuticals, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Theseus Pharmaceuticals Ticker Symbol

Theseus Pharmaceuticals does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Theseus Pharmaceuticals Stock Price

The stock price for Theseus Pharmaceuticals will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Other companies like Theseus Pharmaceuticals in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$317.32MM
Sector
 
 
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$334.19MM